Dutch-based US pharmaceutical giant Mylan's independent foundation said Thursday it will excercise a call option allowing it buy shares to control half the company in fending off a hostile takeover bid by Israeli rival Teva.
The foundation "formed its independent judgement that Mylan's best interests are at risk as a consequence of the uncertainty and threats associated by a possible takeover by Teva," Mylan said in a statement.
Mylan, a US company that moved to the Netherlands a year ago for fiscal reasons, had dismissed Teva's earlier bid in April.
GMT 12:07 2018 Tuesday ,23 January
Syria Kurds urge civilians to take up arms against Turk assaultGMT 12:03 2018 Tuesday ,23 January
Egypt military accuses presidential hopeful of crimes including forgeryGMT 11:41 2018 Tuesday ,23 January
UK regulator says Fox's Sky takeover 'not in public interest'GMT 11:38 2018 Tuesday ,23 January
South African jazz legend Hugh Masekela diesGMT 11:36 2018 Tuesday ,23 January
EU removes eight countries from tax haven listGMT 11:32 2018 Tuesday ,23 January
8.2 magnitude quake hits off Alaska: USGSGMT 11:28 2018 Tuesday ,23 January
Mattis calls for Turkish 'restraint' in SyriaGMT 03:43 2018 Tuesday ,23 January
Turkish soldier killed in Syria operation: armyMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor